EXPERIENCE OF THE COMPANY
As a global investment entity, High Forest has spent the last several years sourcing and supporting companies with cutting-edge technologies in the global market. Below is a list of our track record.
-
Blue Bear Ventures Fund I, L.P. (‘BBV’)
Founded in 2017, BBV is a unique accelerator-based venture fund at the University of California, Berkeley, in which the University participates as a special limited partner in the BBV structure. By the end of 2021, BBV had invested in a total of 19 companies across the fields of gene therapy, nano materials, artificial intelligence-targeted medicine, and synthetic biology. Notable deals include Ayer Labs (the leader in chip-to-chip optical connectivity, solving I/O bandwidth and power bottlenecks), YourChoice (non-hormonal contraceptive products for men), and others. The Company joined in the fund between 2018 and the end of 2021.
View Site -
Genor Biopharma Co. Ltd. (Stock code: 6998.HK)
In October 2020, High Forest participated in the anchor investment of the IPO of Genor Biopharma Co. Ltd., which is an innovation-oriented biopharmaceutical company with a therapeutic development pipeline covering the world's most prevalent cancer types(breast, lung, and gastrointestinal cancer) and hematological malignancies.
View Site -
RNAimmune, INC
In April 2021, High Forest participated in the seed round preferred stock investment in RNAimmune, INC, a company formed in early 2020 that specializes in discovering and developing mRNA therapeutics and vaccine products. Since its inception, the company has built and refined a complete set of technical platforms for mRNA vaccine and new drug development, dedicated to addressing the clinical needs in viral infectious diseases, oncology, and rare diseases.
View Site -
Street 54 Apartment
In 2017, the Company acquired an apartment building located on 54th Street in Manhattan, New York. The building consists of 33 apartments, was well-managed and generated steady cash flow. At present the property is a very popular target for the local acquirers.
View Site
